Development of New Drugs for Autoimmune Hemolytic Anemia

• Autori principali: Zhengrui Xiao (Autore), Irina Murakhovskaya (Autore)
• Natura: Libro
• Pubblicazione: MDPI AG, 2022-05-01T00:00:00Z.
• Soggetti: article
• Accesso online: Connect to this object online.

Autoimmune hemolytic anemia (AIHA) is a rare disorder characterized by the autoantibody-mediated destruction of red blood cells, and treatments for it still remain challenging. Traditional first-line immunosuppressive therapy, which includes corticosteroids and rituximab, is associated with adverse...